483 filings
Page 19 of 25
8-K
pag4o a36wv5co7g8r
7 May 09
Alexza Reports 2009 First Quarter Financial Results and Updates Clinical Pipeline Status
12:00am
8-K
5gr5kjw vm
27 Mar 09
Departure of Directors or Certain Officers
12:00am
DEFA14A
tughjv6od3t lv
27 Mar 09
Additional proxy soliciting materials
12:00am
ARS
af8vbd1dkcqlkj4v
26 Mar 09
Annual report to shareholders
12:00am
S-8
olxie2f77ke5 ym4d
12 Mar 09
Registration of securities for employees
12:00am
8-K
jzm5wjtz9f2sazx4
10 Mar 09
Alexza Reports 2008 Year-End Financial Results and Updates Clinical Pipeline Status
12:00am
8-K
1s5xlc4 paothzcrc
26 Feb 09
Departure of Directors or Certain Officers
12:00am
8-K
7zmla5j7y emcd
24 Feb 09
Departure of Directors or Certain Officers
12:00am
8-K
p1chqcpcb0m0egt2 17u
2 Feb 09
Termination of a Material Definitive Agreement
12:00am
8-K
iupqkv
26 Jan 09
Departure of Directors or Principal Officers
12:00am
8-K
dhl3u93 tf5jusif
20 Jan 09
Regulation FD Disclosure
12:00am
8-K
g9yqsw6vvo1qriobkz
9 Dec 08
Regulation FD Disclosure
12:00am
8-K
yaf5jp1us0srx
6 Nov 08
Alexza Reports 2008 Third Quarter Financial Results and Updates Development of Product Candidates
12:00am
8-K
l67n3kjcx
16 Oct 08
Alexza Completes Enrollment in Second Phase 3 Clinical Trial with AZ-004 (Staccato® Loxapine) for Acute Agitation
12:00am
8-K
541v5rk4s
2 Sep 08
Regulation FD Disclosure
12:00am